BioRestorative Therapies, Inc. (BRTX) vs GeoVax Labs, Inc. (GOVX)
A side-by-side comparison of BioRestorative Therapies, Inc. and GeoVax Labs, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BRTX
BioRestorative Therapies, Inc.
$2.13HealthcareDelayed quote: Oct 6, 2026, 10:43 AM EDT
GOVX
GeoVax Labs, Inc.
$0.30HealthcareDelayed quote: Oct 6, 2026, 10:39 AM EDT
Total return — BRTX vs GOVX
growth of $100 · dividends reinvested · last 8yBRTX -100.0% (-69.3%/yr)GOVX -100.0% (-81.7%/yr)BRTX compounded faster over this window
Log scale — wide-divergence pair
BRTX GOVX
BRTX vs GOVX: by the numbers
- •BRTX is the larger company ($3M vs $2M market cap).
- •Both run net losses; GOVX's is the smaller (-862.34% vs -3089.55% net margin).
Metrics side by side
Valuation
| Metric | BRTX | GOVX |
|---|---|---|
| P/S ratio | 8.22 | N/A |
| P/B ratio | 0.97 | 1.26 |
Profitability
| Metric | BRTX | GOVX |
|---|---|---|
| Gross margin | 92.09% | -628.02% |
| Operating margin | -4350.05% | -869.34% |
| Net margin | -3089.55% | -862.34% |
| ROE | -365.43% | -1160.10% |
| ROIC | -464.86% | -985.20% |
Growth (annualized)
| Metric | BRTX | GOVX |
|---|---|---|
| Revenue CAGR (5Y) | 38.99% | N/A |
| Total return CAGR (5Y) | -61.44% | N/A |
Go deeper
Dig into the metrics
BioRestorative Therapies ROEGeoVax Labs ROEBioRestorative Therapies operating marginGeoVax Labs operating marginBioRestorative Therapies revenue growthGeoVax Labs revenue growthBioRestorative Therapies free cash flowGeoVax Labs free cash flow
BioRestorative Therapies & GeoVax Labs appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.